As of 2025-12-19, the EV/EBITDA ratio of Twist Bioscience Corp (TWST) is -27.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Twist's latest enterprise value is 1,768.86 mil USD. Twist's TTM EBITDA according to its financial statements is -63.29 mil USD. Dividing these 2 quantities gives us the above Twist EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 15.5x | 15.1x |
| Forward P/E multiples | 15.9x - 20.6x | 18.0x |
| Fair Price | (13.48) - (13.09) | (14.14) |
| Upside | -142.2% - -141.0% | -144.3% |
| Date | EV/EBITDA |
| 2025-12-16 | -27.18 |
| 2025-12-15 | -27.13 |
| 2025-12-12 | -26.99 |
| 2025-12-11 | -28.14 |
| 2025-12-10 | -28.78 |
| 2025-12-09 | -27.62 |
| 2025-12-08 | -28.24 |
| 2025-12-05 | -28.31 |
| 2025-12-04 | -28.81 |
| 2025-12-03 | -27.22 |
| 2025-12-02 | -25.80 |
| 2025-12-01 | -25.96 |
| 2025-11-28 | -28.03 |
| 2025-11-26 | -27.73 |
| 2025-11-25 | -27.16 |
| 2025-11-24 | -25.44 |
| 2025-11-21 | -24.70 |
| 2025-11-20 | -22.29 |
| 2025-11-19 | -21.70 |
| 2025-11-18 | -22.23 |
| 2025-11-17 | -22.67 |
| 2025-11-14 | -23.07 |
| 2025-11-13 | -26.00 |
| 2025-11-12 | -27.90 |
| 2025-11-11 | -27.37 |
| 2025-11-10 | -27.02 |
| 2025-11-07 | -26.35 |
| 2025-11-06 | -26.70 |
| 2025-11-05 | -27.56 |
| 2025-11-04 | -26.15 |
| 2025-11-03 | -27.61 |
| 2025-10-31 | -28.88 |
| 2025-10-30 | -27.22 |
| 2025-10-29 | -28.23 |
| 2025-10-28 | -29.54 |
| 2025-10-27 | -30.13 |
| 2025-10-24 | -30.06 |
| 2025-10-23 | -27.86 |
| 2025-10-22 | -27.12 |
| 2025-10-21 | -29.37 |
| 2025-10-20 | -28.74 |
| 2025-10-17 | -24.31 |
| 2025-10-16 | -26.82 |
| 2025-10-15 | -28.06 |
| 2025-10-14 | -26.62 |
| 2025-10-13 | -26.23 |
| 2025-10-10 | -27.24 |
| 2025-10-09 | -27.92 |
| 2025-10-08 | -28.79 |
| 2025-10-07 | -27.17 |